Ayala Pharmaceuticals Inc

NASDAQ:AYLA  
8.99
-0.36 (-3.85%)
Earnings Announcements

Ayala Pharmaceuticals Reports Third Quarter 2021 Financial Results

Published: 11/15/2021 13:50 GMT
Ayala Pharmaceuticals Inc (AYLA) - Ayala Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business Update.
Q3 Loss per Share $0.68.
Expects to Report Preliminary Data From Phase 2 Tenacity Trial of Al101 in 2022.
Q3 Earnings per Share View $-0.80 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0.93 Million
Adjusted EPS is expected to be -$0.61

Next Quarter Revenue Guidance is expected to be $0.88 Million
Next Quarter EPS Guidance is expected to be -$0.61

More details on our Analysts Page.